| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| ChEMBL | |
| Chemical and physical data | |
| Formula | C24H35N3O2 |
| Molar mass | 397.563 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Org 28312 is a drug developed byOrganon International which acts as a potentcannabinoidreceptorfull agonist at both theCB1 andCB2 receptors. It was developed with the aim of finding awater-soluble cannabinoid agonist suitable forintravenous use as ananalgesic, but did not proceed to human trials, with the related compoundOrg 28611 chosen instead due to its better penetration into the brain.[1] Thestructure-activity relationships of these compounds have subsequently been investigated further leading to the development of a number of more potent analogues, derived bycyclisation around theindole orpiperazine rings.[2][3]
Thiscannabinoid related article is astub. You can help Wikipedia byadding missing information. |